ScrutarSign up free

DME Capital Management (David Einhorn)

Famous investors & activists

Files as DME Capital Management, LP (formerly Greenlight Capital) (SEC CIK 1489933).
Portfolio from its latest quarterly 13F-HR filing.

$5.23B
Tracked value
46
Positions
Q2 2026
Portfolio as of
Aug 14, 2026
Filed

Holdings

#CompanyPortfolio %vs Q1 2026Value
1GPROGoPro, Inc.25.2%unch.$1.32B
2GRBKGreen Brick Partners, Inc.14.5%unch.$757.77M
3FLRFLUOR CORP4.7%▼ 1.9%$244.07M
4CNRCore Natural Resources, Inc.3.5%▲ 22.9%$182.70M
5BHFBrighthouse Financial, Inc.3.4%unch.$179.90M
6ACHCAcadia Healthcare Company, Inc.2.5%▼ 2.6%$129.95M
7PENNPENN Entertainment, Inc.2.4%▼ 3.0%$125.18M
8FBINFortune Brands Innovations, Inc.2.4%NEW$123.08M
9PCGPG&E Corp2.1%unch.$111.56M
10CNCCENTENE CORP2.0%▼ 39.6%$105.99M
11GPKGRAPHIC PACKAGING HOLDING CO2.0%▲ 9.4%$105.21M
12SNXTD SYNNEX CORP1.9%▼ 20.5%$101.87M
13TEVATEVA PHARMACEUTICAL INDUSTRIES LTD1.9%▼ 0.8%$97.78M
14VGNTVersigent PLC1.8%NEW$95.68M
15CPRICapri Holdings Ltd1.7%▼ 2.2%$89.51M
16BKVBKV Corp1.6%▲ 14.8%$84.68M
17DHTDHT Holdings, Inc.1.6%▼ 4.5%$83.22M
18CROXCrocs, Inc.1.5%unch.$80.73M
19ROIVRoivant Sciences Ltd.1.5%unch.$76.18M
20SHCSotera Health Co1.4%▲ 100%$73.41M
21VSNTVersant Media Group, Inc.1.3%▼ 36.5%$69.22M
22PRMBPrimo Brands Corp1.3%NEW$69.01M
23DCHDauch Corp1.3%▲ 96.4%$67.18M
24PYPLPayPal Holdings, Inc.1.2%NEW$61.50M
25HSICHENRY SCHEIN INC1.1%▲ 19.9%$60.01M
26WBDWarner Bros. Discovery, Inc.1.1%NEW$59.88M
27LBTYALiberty Global Ltd.1.1%unch.$56.43M
28ARANTERO RESOURCES Corp1.1%▲ 94.7%$55.32M
29STUBStubHub Holdings, Inc.1.0%unch.$54.48M
30REZIRESIDEO TECHNOLOGIES, INC.1.0%▲ 7.9%$52.86M
31DECKDECKERS OUTDOOR CORP1.0%▲ 5.2%$50.28M
32SPBSpectrum Brands Holdings, Inc.0.9%▼ 13.7%$48.14M
33CNHCNH Industrial N.V.0.9%unch.$47.04M
34VTRSViatris Inc0.8%▲ 52.6%$44.04M
35PSKYParamount Skydance Corp0.7%unch.$38.71M
36PVHPVH CORP. /DE/0.7%NEW$38.67M
37CMCSACOMCAST CORP0.6%NEW$33.04M
38SLDESlide Insurance Holdings, Inc.0.6%unch.$32.67M
39TRIPTripAdvisor, Inc.0.6%▲ 51.0%$32.38M
40GLDSPDR GOLD TRUST0.6%▼ 16.3%$30.73M
41CICigna Group0.5%unch.$24.37M
42LKFTLakefront Biotherapeutics NV0.3%unch.$14.47M
43COYACoya Therapeutics, Inc.0.3%unch.$13.66M
44IMVTImmunovant, Inc.0.1%unch.$3.60M
45GANXGain Therapeutics, Inc.0.0%unch.$1.15M
46NUVBNuvation Bio Inc.0.0%unch.$198.8K

Positions in companies tracked by Scrutar, from the manager's latest quarterly 13F-HR filing.
13F filings disclose US-listed long positions only and can be filed up to 45 days after quarter end, so the portfolio may have changed since.
Portfolio % is each position's share of the tracked value shown above. Changes compare share counts against the Q1 2026 filing, adjusted for stock splits.

Never miss a DME Capital Management (David Einhorn) 13F.

Get an email when DME Capital Management (David Einhorn) files its next quarterly 13F with the SEC, including the portfolio's notable changes. Free, no account needed.

Free foreverNo account requiredOne-click unsubscribe

Protected by reCAPTCHA. Privacy & Terms

Source: SEC EDGAR Form 13F-HR filings.